1.Gastrointestinal stromal tumors as an incidental finding in patients with a presumptive diagnosis of ovarian cancer.
Mario MUNOZ ; Pedro T RAMIREZ ; Carolina ECHEVERRI ; Luis Guillermo ALVAREZ ; Maria Alejandra PALOMINO ; Luis Rene PAREJA
Journal of Gynecologic Oncology 2012;23(1):48-52
OBJECTIVE: To report the clinical presentation and oncologic outcomes of a series of patients who presented with an abdominal or pelvic mass and were diagnosed with a gastrointestinal stromal tumor (GIST). METHODS: Data were obtained on all patients who presented with an abdominal or pelvic mass between September 2007 and June 2010 and who were ultimately diagnosed with a GIST. The patients' medical records were reviewed. A literature review was also conducted. RESULTS: Six patients were identified who met the inclusion criteria. All six patients had a tumor in the intestinal tract arising from the small bowel. The mean tumor size was 12 cm (range, 6 to 22 cm). A complete resection was achieved in five of the six patients. There were no intraoperative complications; one patient had a postoperative complication. Two patients were treated with imatinib after surgery. The mean follow-up time was 32 months (range, 0.3 to 40 months). At the last follow-up, five of the six patients were without any evidence of disease. One patient died of an unrelated hepatic encephalopathy. The incidence in our institution is 3%. CONCLUSION: GISTs are uncommon; however, they should be considered in the differential diagnosis of patients presenting with an abdominal or pelvic mass.
Benzamides
;
Diagnosis, Differential
;
Follow-Up Studies
;
Gastrointestinal Stromal Tumors
;
Hepatic Encephalopathy
;
Humans
;
Imatinib Mesylate
;
Incidence
;
Incidental Findings
;
Medical Records
;
Ovarian Neoplasms
;
Piperazines
;
Postoperative Complications
;
Pyrimidines
2.The Learning Curve for Peroral Endoscopic Myotomy in Latin America: A Slide to the Right?
Michel KAHALEH ; Amy TYBERG ; Supriya SURESH ; Arnon LAMBROZA ; Fernando Rodriguez CASAS ; Mario REY ; Jose NIETO ; Guadalupe Ma MARTÍNEZ ; Felipe ZAMARRIPA ; Vitor ARANTES ; Maria G PORFILIO ; Monica GAIDHANE ; Pietro FAMILIARI ; Juan Carlos CARAMES ; Romulo VARGAS-RUBIO ; Raul CANADAS ; Albis HANI ; Guillermo MUNOZ ; Bismarck CASTILLO ; Eduardo T MOURA ; Farias F GALILEU ; Hannah P LUKASHOK ; Carlos ROBLES-MEDRANDA ; Eduardo G de MOURA
Clinical Endoscopy 2021;54(5):701-705
Background/Aims:
Per oral endoscopic myotomy (POEM) has been increasingly used for achalasia in Latin America, where Chagas disease is prevalent, and this makes POEM more challenging. The aim of this study was to determine the learning curve for POEM in Latin America.
Methods:
Patients undergoing POEM in Latin America with a single operator were included from a prospective registry over 4 years. Non-linear regression and cumulative sum control chart (CUSUM) analyses were conducted for the learning curve.
Results:
A total of 125 patients were included (52% male; mean age, 59 years), of which 80 had type II achalasia (64%), and 38 had Chagas disease (30%). The average pre-procedure and post-procedure Eckardt scores were 6.79 and 1.87, respectively. Technical success was achieved in 93.5% of patients, and clinical success was achieved in 88.8%. Adverse events occurred in 27 patients (22%) and included bleeding (4 patients), pneumothorax (4 patients), mucosal perforation (13 patients), mediastinitis (2 patients), and leakage (4 patients).
The CUSUM chart showed a median procedure time of 97 min (range, 45-196 min), which was achieved at the 61st procedure. Procedure duration progressively decreased, with the last 10 procedures under 50 min approaching a plateau (p-value <0.01).
Conclusions
Mastering POEM in Latin America requires approximately 61 procedures for both POEM efficiency and to accomplish the procedure within 97 minutes.
3.The Learning Curve for Peroral Endoscopic Myotomy in Latin America: A Slide to the Right?
Michel KAHALEH ; Amy TYBERG ; Supriya SURESH ; Arnon LAMBROZA ; Fernando Rodriguez CASAS ; Mario REY ; Jose NIETO ; Guadalupe Ma MARTÍNEZ ; Felipe ZAMARRIPA ; Vitor ARANTES ; Maria G PORFILIO ; Monica GAIDHANE ; Pietro FAMILIARI ; Juan Carlos CARAMES ; Romulo VARGAS-RUBIO ; Raul CANADAS ; Albis HANI ; Guillermo MUNOZ ; Bismarck CASTILLO ; Eduardo T MOURA ; Farias F GALILEU ; Hannah P LUKASHOK ; Carlos ROBLES-MEDRANDA ; Eduardo G de MOURA
Clinical Endoscopy 2021;54(5):701-705
Background/Aims:
Per oral endoscopic myotomy (POEM) has been increasingly used for achalasia in Latin America, where Chagas disease is prevalent, and this makes POEM more challenging. The aim of this study was to determine the learning curve for POEM in Latin America.
Methods:
Patients undergoing POEM in Latin America with a single operator were included from a prospective registry over 4 years. Non-linear regression and cumulative sum control chart (CUSUM) analyses were conducted for the learning curve.
Results:
A total of 125 patients were included (52% male; mean age, 59 years), of which 80 had type II achalasia (64%), and 38 had Chagas disease (30%). The average pre-procedure and post-procedure Eckardt scores were 6.79 and 1.87, respectively. Technical success was achieved in 93.5% of patients, and clinical success was achieved in 88.8%. Adverse events occurred in 27 patients (22%) and included bleeding (4 patients), pneumothorax (4 patients), mucosal perforation (13 patients), mediastinitis (2 patients), and leakage (4 patients).
The CUSUM chart showed a median procedure time of 97 min (range, 45-196 min), which was achieved at the 61st procedure. Procedure duration progressively decreased, with the last 10 procedures under 50 min approaching a plateau (p-value <0.01).
Conclusions
Mastering POEM in Latin America requires approximately 61 procedures for both POEM efficiency and to accomplish the procedure within 97 minutes.